Craig o

[Craig o @c_olvrin]

@Canucksforkids @Canucks Inspiring stuff Tyson! Keep at it!

[Craig o @c_olvrin]

@CanucksArmy No

[Craig o @c_olvrin]

@Smil3yAngel Donny Tiny Hands

[Craig o @c_olvrin]

@ASC Love ya!!

[Craig o @c_olvrin]

@ASC Oh James I am so so sorry to hear this. That time we spent together in SD with you and Christine was so lovely. She was a beautiful soul. My heart aches. If there is any way I can help you, don’t hesitate! Love you bro!

[Craig o @c_olvrin]

@nugsnet @deadandcompany Where can I open a ticket? Could you send me a link please?

[Craig o @c_olvrin]

@nugsnet We want to thank https://t.co/aXoW5GhEWr for a real good time….NOT!

[Craig o @c_olvrin]

@GratefulDead Get in the groove and let the good times roll
We're gonna stay here till we soothe our soul
If it takes all night long

[Craig o @c_olvrin]

@ASC Sorry buddy. We’re sending you love from hakuba.

[Mindgames @mindgameslab]

Balance+
Peter Van Hoesen

5月20日(金曜)〜22日(日曜)
水上宝台樹キャンプ場

https://t.co/oWPau1gw46

[Craig o @c_olvrin]

@Lynseyfenlou I’m so sorry.

[Craig o @c_olvrin]

@mnmlssgs perfect vibe on this Ny`s day.

[Craig o @c_olvrin]

@AkalStation @aob4227O @braintumorshare I’m not sure but I will meet the doctors involved at the end of this month andcwill find out for you Alex.

[Craig o @c_olvrin]

@aob4227O @braintumorshare Yes. It has been approved conditionally in Japan & is being administered as of this month (nov 2021) only at Tokyo University for now. And soon at other hospitals around Japan. It`s been renamed "Delytact" - https://t.co/K2Jh4xv4k8

[Craig o @c_olvrin]

@russmonk I think that’s the first thing I’ve posted in 5 years. Love that book!

[Craig o @c_olvrin]

@russmonk The chrysalids was standard curriculum in canada grade 8 English. Along with Lord of the Flies & the Outsiders

[Craig o @c_olvrin]

@aob4227O @braintumorshare Yesterday in Japan the MHLW Panel Backs Japan’s 1st Oncolytic Virus for Conditional Approval!!! #G47∆ #Teserpaturev

[Craig o @c_olvrin]

@aob4227O @braintumorshare Yes it`s approval in Japan is being discussed today May 24th 2021 - A key Japanese health ministry panel will review whether to back approval of Daiichi Sankyo’s sakigake-designated oncolytic virus G47∆ (teserpaturev) on May 24 for an indication of malignant glioma.

[Craig o @c_olvrin]

@aob4227O @BeaconIntel I`m following it as closely as i can ( i live in Japan & know Dr. Todou). If i get some news, i`ll message you but it could take a few days.

[Craig o @c_olvrin]

@aob4227O @BeaconIntel Yes. It is under review Today (May 24th) - A key Japanese health ministry panel will review whether to back approval of Daiichi Sankyo’s sakigake-designated oncolytic virus G47∆ (teserpaturev) on May 24 for an indication of malignant glioma.

[Craig o @c_olvrin]

@aob4227O @BeaconIntel If this body endorses it today, it`s likley to get full approval in Japan by the end of June 2021. https://t.co/lOUhetsRP1